Works about BRAF genes
Results: 2658
Combinational Inhibition of MEK and AKT Synergistically Induces Melanoma Stem Cell Apoptosis and Blocks NRAS Tumor Growth.
- Published in:
- Cells (2073-4409), 2025, v. 14, n. 4, p. 248, doi. 10.3390/cells14040248
- By:
- Publication type:
- Article
Spontaneous Necrosis of a High-Risk Bladder Tumor Under Immunotherapy for Concurrent Malignant Melanoma: Role of BRAF Mutations and PD-L1 Expression.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 377, doi. 10.3390/biomedicines13020377
- By:
- Publication type:
- Article
A remarkable and durable response to tislelizumab treatment of an anaplastic thyroid carcinoma without targetable genomic alterations: a case report.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
An MGRN1 -Based Biomarker Combination Accurately Predicts Melanoma Patient Survival.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1739, doi. 10.3390/ijms26041739
- By:
- Publication type:
- Article
Immunohistochemical and transcriptomic characterization of T and myeloid cell infiltrates in canine malignant melanoma.
- Published in:
- Veterinary & Comparative Oncology, 2024, v. 22, n. 3, p. 377, doi. 10.1111/vco.12981
- By:
- Publication type:
- Article
Effective detection of BRAF<sup>V595E</sup> mutation in canine urothelial and prostate carcinomas using immunohistochemistry.
- Published in:
- Veterinary & Comparative Oncology, 2024, v. 22, n. 2, p. 295, doi. 10.1111/vco.12978
- By:
- Publication type:
- Article
Establishment of a BRAF V595E‐mutant canine prostate cancer cell line and the antitumor effects of MEK inhibitors against canine prostate cancer.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 221, doi. 10.1111/vco.12879
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 1, p. 1, doi. 10.1111/vco.12883
- By:
- Publication type:
- Article
Highly recurrent BRAF p.V595E mutation in canine papillary oral squamous cell carcinoma.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 1, p. 138, doi. 10.1111/vco.12869
- By:
- Publication type:
- Article
BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006–2019).
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 449, doi. 10.1111/vco.12790
- By:
- Publication type:
- Article
An open‐label dose escalation study evaluating tolerability and safety of a single 5‐days course of temozolomide in dogs with advanced cancer.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 4, p. 838, doi. 10.1111/vco.12623
- By:
- Publication type:
- Article
Long interspersed nucleotide element‐1 hypomethylation in canine malignant mucosal melanoma.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 4, p. 854, doi. 10.1111/vco.12591
- By:
- Publication type:
- Article
Longitudinal transcriptomic and genetic landscape of radiotherapy response in canine melanoma.
- Published in:
- Veterinary & Comparative Oncology, 2019, v. 17, n. 3, p. 308, doi. 10.1111/vco.12473
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Developmental Dynamics, 2021, v. 250, n. 8, p. i, doi. 10.1002/dvdy.404
- Publication type:
- Article
BRAF Mutations Are Also Associated with Neurocutaneous Melanocytosis and Large/Giant Congenital Melanocytic Nevi.
- Published in:
- Pediatric & Developmental Pathology, 2015, v. 18, n. 1, p. 1, doi. 10.2350/14-10-1566-OA.1
- By:
- Publication type:
- Article
Global trends in research of melanoma differentiation-associated gene 5: a bibliometric analysis from 2002 to 2022.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 3, p. 1111, doi. 10.1007/s10067-023-06851-x
- By:
- Publication type:
- Article
Tofacitinib for new-onset adult patients with anti-melanoma differentiation-associated 5 gene antibody positive dermatomyositis.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 7, p. 1847, doi. 10.1007/s10067-023-06567-y
- By:
- Publication type:
- Article
Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma.
- Published in:
- Surgery Today, 2016, v. 46, n. 9, p. 1091, doi. 10.1007/s00595-015-1295-z
- By:
- Publication type:
- Article
Genomic subtypes of cutaneous melanoma have distinct metabolic profiles: A single-cell transcriptomic analysis.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 10, p. 2961, doi. 10.1007/s00403-023-02690-7
- By:
- Publication type:
- Article
Genomic comparison between an in vitro three-dimensional culture model of melanoma and the original primary tumor.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 5, p. 1225, doi. 10.1007/s00403-022-02502-4
- By:
- Publication type:
- Article
Merkel cell polyomavirus and human papilloma virus in proliferative skin lesions arising in patients treated with BRAF inhibitors.
- Published in:
- Archives of Dermatological Research, 2016, v. 308, n. 5, p. 357, doi. 10.1007/s00403-016-1650-y
- By:
- Publication type:
- Article
MAP kinase activity supported by BRAF mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.
- Published in:
- Archives of Dermatological Research, 2014, v. 306, n. 10, p. 873, doi. 10.1007/s00403-014-1490-6
- By:
- Publication type:
- Article
Epigenetic alterations in sporadic basal cell carcinomas.
- Published in:
- Archives of Dermatological Research, 2014, v. 306, n. 6, p. 561, doi. 10.1007/s00403-014-1454-x
- By:
- Publication type:
- Article
Dabrafenib monotherapy for a recurrent BRAFV600E-mutated TTF-1-positive posterior pituitary tumor.
- Published in:
- Acta Neurochirurgica, 2022, v. 164, n. 3, p. 737, doi. 10.1007/s00701-022-05109-w
- By:
- Publication type:
- Article
Lysine-specific demethylase 1 cooperates with BRAF-histone deacetylase complex 80 to enhance HIV-1 Tat-mediated transactivation.
- Published in:
- Virus Genes, 2018, v. 54, n. 5, p. 662, doi. 10.1007/s11262-018-1589-5
- By:
- Publication type:
- Article
BRAF mutant appendiceal adenocarcinoma differs from colorectal cancer but responds to BRAF-targeted therapy.
- Published in:
- NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-00821-z
- By:
- Publication type:
- Article
Clinical associations and genetic interactions of oncogenic BRAF alleles.
- Published in:
- PeerJ, 2022, p. 1, doi. 10.7717/peerj.14126
- By:
- Publication type:
- Article
Analysis of multi-omics differences in left-side and right-side colon cancer.
- Published in:
- PeerJ, 2021, p. 1, doi. 10.7717/peerj.11433
- By:
- Publication type:
- Article
ARID1A alterations and their clinical significance in cholangiocarcinoma.
- Published in:
- PeerJ, 2020, p. 1, doi. 10.7717/peerj.10464
- By:
- Publication type:
- Article
Correlation between obesity and clinicopathological characteristics in patients with papillary thyroid cancer: a study of 1579 cases: a retrospective study.
- Published in:
- PeerJ, 2020, p. 1, doi. 10.7717/peerj.9675
- By:
- Publication type:
- Article
Monensin may inhibit melanoma by regulating the selection between differentiation and stemness of melanoma stem cells.
- Published in:
- PeerJ, 2019, p. 1, doi. 10.7717/peerj.7354
- By:
- Publication type:
- Article
The impact of patient involvement in research: a case study of the planning, conduct and dissemination of a clinical, controlled trial.
- Published in:
- Research Involvement & Engagement, 2020, v. 6, n. 1, p. 1, doi. 10.1186/s40900-020-00214-5
- By:
- Publication type:
- Article
Melanoma: clinic-pathological and molecular analyses in patients from Ibague, Colombia.
- Published in:
- Duazary. Revista de la Facultad de Ciencias de la Salud, 2020, v. 17, n. 1, p. 5, doi. 10.21676/2389783X.3217
- By:
- Publication type:
- Article
The Role of BPTF in Melanoma Progression and in Response to BRAF-Targeted Therapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 5, p. 1, doi. 10.1093/jnci/djv034
- By:
- Publication type:
- Article
Role of BRAFV600E in the First Preclinical Model of Multifocal Infiltrating Myopericytoma Development and Microenvironment.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 8, p. 1, doi. 10.1093/jnci/dju182
- By:
- Publication type:
- Article
Re: Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Response.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2201408
- By:
- Publication type:
- Article
Imidazothiazole-based potent inhibitors of V600E-B-RAF kinase with promising anti-melanoma activity: biological and computational studies.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2020, v. 35, n. 1, p. 1712, doi. 10.1080/14756366.2020.1819260
- By:
- Publication type:
- Article
The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2020, v. 35, n. 1, p. 1185, doi. 10.1080/14756366.2020.1764549
- By:
- Publication type:
- Article
The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2019, v. 34, n. 1, p. 117, doi. 10.1080/14756366.2018.1532419
- By:
- Publication type:
- Article
Lineage-coupled clonal capture identifies clonal evolution mechanisms and vulnerabilities of BRAF<sup>V600E</sup> inhibition resistance in melanoma.
- Published in:
- Cell Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41421-022-00462-7
- By:
- Publication type:
- Article
Genetic alterations landscape of lung cancer patients and their therapeutic value: an overview.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 329, doi. 10.33320/10.33320/maced.pharm.bull.2022.68.03.158
- By:
- Publication type:
- Article
Epidemiology, Clinic-histopathological features and Surgical treatment of Papillary Thyroid Cancer: A Retrospective Descriptive Study in Northwestern Algeria.
- Published in:
- Egyptian Academic Journal of Biological Sciences, C Physiology & Molecular Biology, 2023, v. 15, n. 1, p. 225, doi. 10.21608/EAJBSC.2023.289664
- By:
- Publication type:
- Article
Rapid onset and unpredicted findings of a giant nodular melanoma arising on a congenital nevus: a case report.
- Published in:
- Oxford Medical Case Reports, 2022, v. 2022, n. 11, p. 1, doi. 10.1093/omcr/omac128
- By:
- Publication type:
- Article
Consistent absence of BRAF mutations in salivary gland carcinomas.
- Published in:
- Journal of Dental Materials & Techniques, 2017, v. 6, n. 2, p. 73
- By:
- Publication type:
- Article
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00922-7
- By:
- Publication type:
- Article
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 12, p. 1, doi. 10.1038/s41408-022-00760-z
- By:
- Publication type:
- Article
Clinical and therapeutic implications of BRAF fusions in histiocytic disorders.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00693-7
- By:
- Publication type:
- Article
Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-86694-5
- By:
- Publication type:
- Article